Sign up
Pharma Capital

Ixico leverages patient technologies and introduces wearables

Guilio Cerroni, CEO of Ixico  (LON:IXI) tells Proactive why the pharmaceuticals-serving business is expanding and why all of us  longer lives also means it's a new and expanding area for investment.
Outlining his vision for a future growth strategy Guilio tells Proactive about new forays into wearable bio-sensors and human sleep patterns as focus shifts more towards patient outcomes and much less to drugs dispensing.

 

View full IXI profile

IXICO Plc Timeline

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.